Hologic, Inc. provided preliminary revenue guidance for first fiscal quarter ended December 25, 2021. For the quarter, the company expects to report total revenues of approximately $1,471.1 million, a decrease of (8.6%) compared to the prior year period, or (8.2%) in constant currency. These preliminary results compare to the Company's most recent guidance range of $1,100 to $1,150 million, which was provided on November 1, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.21 USD | +2.68% |
|
+2.77% | +3.86% |
27/06 | Stephens Initiates Coverage on Hologic With Overweight Rating, $87 Price Target | MT |
19/06 | Lumos Diagnostics Receives $400,000 in Milestone Payment from Hologic; Shares Up 3% | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.86% | 1.73TCr | |
+3.77% | 21TCr | |
+8.83% | 19TCr | |
+31.94% | 16TCr | |
+33.19% | 11TCr | |
+5.25% | 6.61TCr | |
+22.41% | 5.62TCr | |
+1.34% | 4.9TCr | |
-5.92% | 3.82TCr | |
+1.94% | 3.6TCr |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Hologic, Inc. Provides Preliminary Revenue Guidance for First Fiscal Quarter Ended December 25, 2021